Market cap
$60,583 Mln
Recently Viewed
Clear All$306.59
$-1.42
(-0.46%)
As on 01-May-2026 10:45EDT
Market cap
$60,583 Mln
Revenue (TTM)
$325,778 Mln
P/E Ratio
37.4
P/B Ratio
31.8
Div. Yield
0.7 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$1,625 Mln
ROE
1.3 %
ROCE
-- %
Industry P/E
26.69
EV/EBITDA
17.1
Debt to Equity
4
Book Value
$9.8
EPS
$8.3
Face value
--
Shares outstanding
194,530,682
CFO
$26,795.61 Mln
EBITDA
$17,941.68 Mln
Net Profit
$3,142.60 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| -9.2 | -2.4 | -14.7 | 4.8 | 22.5 | 20.5 | 13.7 |
|
BSE Sensex*
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Midcap 400
| 9.0 | 11.1 | 6.2 | 27.8 | 13.6 | 5.7 | 9.6 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| 50.3 | 9.3 | 23.9 | 40.2 | 16.5 | 34.1 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
|
306.6 | 60,582.7 | 325,777.8 | 1,625.2 | 0.9 | 82.8 | 37.4 | 31.8 |
| 183.3 | 83,102.5 | 10,645.1 | 2,529.8 | 41.4 | 71.9 | 28.7 | 23.6 | |
| 199.8 | 69,090.8 | 5,086.1 | 1,186.2 | 36.7 | 10.2 | 51.6 | 3.0 | |
| 143.5 | 30,009.0 | 3,377.5 | 974.0 | 73.3 | 7.1 | 31 | 2.2 | |
| 126.0 | 34,516.5 | 6,901.7 | 144.6 | 16.4 | -33.2 | 236.8 | 1,516.5 | |
| 302.1 | 54,117.9 | 4,824.1 | 1,784.4 | 43.4 | 18.8 | 34.3 | 11.1 | |
| 220.3 | 22,906.3 | 2,815.1 | 1,053.6 | 60.8 | -21.1 | 22 | 91.0 | |
| 87.9 | 39,758.2 | 5,834.0 | 251.4 | 14.7 | 2.2 | 154.9 | 3.1 | |
| 217.2 | 147,070.8 | 10,667.1 | 936.9 | 1.6 | 2.5 | 147 | 3.5 | |
| 24.7 | 18,047.7 | 6,905.0 | 324.0 | 7.7 | 3.4 | 55.6 | 1.9 |
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home... healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. Address: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 Read more
Chairman, President & CEO
Mr. Steven H. Collis
Executive Chairman
Mr. Steven H. Collis
Headquarters
Conshohocken, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of CoreSite Realty Corporation (COR) is $306.59 (NYSE) as of 01-May-2026 10:45 EDT. CoreSite Realty Corporation (COR) has given a return of 22.48% in the last 3 years.
The P/E ratio of CoreSite Realty Corporation (COR) is 37.43 times as on 30-Apr-2026, a 40 premium to its peers’ median range of 26.69 times.
The P/B ratio of CoreSite Realty Corporation (COR) is 31.80 times as on 30-Apr-2026, a 1717 premium to its peers’ median range of 1.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
38.99
|
40.18
|
|
2024
|
29.87
|
69.79
|
|
2023
|
20.97
|
70.12
|
|
2022
|
16.72
|
-134.29
|
|
2021
|
16.35
|
112.74
|
The 52-week high and low of CoreSite Realty Corporation (COR) are Rs 377.54 and Rs 273.43 as of 01-May-2026.
CoreSite Realty Corporation (COR) has a market capitalisation of $ 60,583 Mln as on 30-Apr-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in CoreSite Realty Corporation (COR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.